 | Doramapimod | IC50 | 6.0 [1], 10.0 [2], 98.0 [3], 150.0 [4], 1000.0 [5] |
 | 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 320.0 [1] |
 | JNK Inhibitor V | IC50 | 220.0 [1], 5000.0 [2] |
 | 1,9-Pyrazoloanthrone | IC50 | 40.0 [1] |
 | Jnk-IN-8 | IC50 | 1.0 [1], 18.7 [2] |
 | 4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amine | IC50 | 1170.0 [1], 2200.0 [2] |
 | Methyl 6-bromo-2-[(4-methylsulfonylphenyl)methyl]-1-oxo-4-phenylisoquinoline-3-carboxylate | IC50 | 30.0 [1], 34.0 [2], 72.0 [3] |
 | 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide | IC50 | 200000.0 [1] |
| 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide | Ki | 400000.0 [1] |
 | JNK Inhibitor VIII | IC50 | 160.0 [1] |
| JNK Inhibitor VIII | Ki | 4.0 [1] |
 | Tanzisertib | IC50 | 7.0 [1] |
| Tanzisertib | Ki | 6.2 [1] |
 | Amg-548 | IC50 | 76.0 [1], 220.0 [2] |
 | 1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea | IC50 | 70.0 [1], 90.0 [2] |
 | 4-Amino-5-cyano-6-ethoxy-N-[(4-methylsulfonylphenyl)methyl]pyridine-2-carboxamide | IC50 | 120.0 [1] |
 | 4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyrimidin-2-amine | IC50 | 675.0 [1], 1550.0 [2] |
 | 1-[3-Tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)phenyl]urea | IC50 | 1800.0 [1], 12600.0 [2] |
 | 5-[(2S,3S,4R,5S)-5-(1,3-Benzodioxol-5-yl)-3,4-dimethyloxolan-2-yl]-1,3-benzodioxole | IC50 | 2200.0 [1], 2500.0 [2] |
 | 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | IC50 | 74.0 [1] |
 | 4-[3-(4-Fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine | IC50 | 1280.0 [1] |
 | 1-{4-[(6-Aminoquinazolin-4-Yl)amino]phenyl}-3-[3-Tert-Butyl-1-(3-Methylphenyl)-1h-Pyrazol-5-Yl]urea | IC50 | 570.0 [1], 770.0 [2] |
 | 1-{3-[(6-Aminoquinazolin-4-yl)amino]phenyl}-3-[3-tert-butyl-1-(3-methylphenyl)-1H-pyrazol-5-yl]urea | IC50 | 150.0 [1], 1200.0 [2] |
 | N-[[5-[4-(Benzotriazol-1-yl)piperidin-1-yl]sulfonylthiophen-2-yl]methyl]-4-chlorobenzamide | IC50 | 650.0 [1] |
 | 1-Benzyl-4-(benzyloxy)-3-bromopyridin-2(1H)-one | IC50 | 200000.0 [1] |
 | 3-Bromo-4-[(2,4-difluorophenyl)methoxy]-1-[[4-[(dimethylamino)methyl]phenyl]methyl]-6-methylpyridin-2-one | IC50 | 171000.0 [1], 200000.0 [2] |
 | Methyl 3-[2-(2-thienyl)acetamido]thiophene-2-carboxylate | IC50 | 21400.0 [1], 23000.0 [2] |
 | 2,4-Bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid | IC50 | 10700.0 [1], 43000.0 [2] |
 | 1-{3-[(6-Aminoquinazolin-4-Yl)amino]phenyl}-3-[3-Tert-Butyl-1-(4-Methylphenyl)-1h-Pyrazol-5-Yl]urea | IC50 | 1400.0 [1], 1900.0 [2] |
 | 1-(3-Tert-butyl-1-m-tolyl-1H-pyrazol-5-yl)-3-(4-chlorophenyl)urea | IC50 | 440.0 [1], 1300.0 [2] |
 | N-[4-Bromo-3-(1H-1,2,4-triazol-5-yl)thiophen-2-yl]-2-(2-oxo-3,4-dihydroquinolin-1-yl)acetamide | IC50 | 42.0 [1] |
 | trans-4-[(4-{4-[3-(Methylsulfonyl)propoxy]-1h-Indazol-1-Yl}pyrimidin-2-Yl)amino]cyclohexanol | IC50 | 24.0 [1] |
 | 4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1R)-1-phenylethyl]pyrimidin-2-amine | IC50 | 300.0 [1], 675.0 [2] |
 | Pyridine, 4-(2-(4-fluorophenyl)-5-(4-(methylsulfinyl)phenyl)-1H-pyrrol-3-yl)- | IC50 | 1500.0 [1], 7610.0 [2] |
 | 4-[6-Morpholin-4-yl-3-[3-(trifluoromethyl)phenyl]pyridazin-4-yl]-N-[(1S)-1-phenylethyl]pyrimidin-2-amine | IC50 | 820.0 [1], 1400.0 [2] |
 | 1-Ethyl-3-[4-[(7-oxo-8-propan-2-ylpyrido[2,3-d]pyrimidin-2-yl)amino]cyclohexyl]urea | IC50 | 26.0 [1], 61.0 [2] |
 | 2-Methyl-N-[4-[(7-oxo-8-propan-2-ylpyrido[2,3-d]pyrimidin-2-yl)amino]cyclohexyl]propanamide | IC50 | 29.0 [1], 143.0 [2] |
 | [(E)-[(5Z)-5-(1,3-Benzodioxol-5-ylmethylidene)-4-oxo-1,3-thiazolidin-2-ylidene]amino]thiourea | IC50 | 630.0 [1], 1700.0 [2] |
 | Naphtho(2',1':4,5)(1,3)thiazolo(2,3-c)(1,2,4)triazole, 8-(4-methoxyphenyl)- | IC50 | 21500.0 [1], 41000.0 [2] |
 | 2-((8-(2,3-Dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)amino)ethanol | IC50 | 2200.0 [1] |
 | 3-[(4-Methylphenyl)diazenyl]-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-2-amine | IC50 | 14500.0 [1], 20000.0 [2] |
 | 10-[(4-Methoxyphenyl)diazenyl]-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-11-amine | IC50 | 7800.0 [1], 15500.0 [2] |
 | 2-[[5-Chloro-2-(2-methoxy-4-morpholin-4-ylanilino)pyridin-4-yl]amino]-N-methylbenzamide | IC50 | 50.0 [1] |
 | 1-{4-[(6-Aminoquinolin-4-Yl)amino]phenyl}-3-[3-Tert-Butyl-1-(3-Methylphenyl)-1h-Pyrazol-5-Yl]urea | IC50 | 100.0 [1], 380.0 [2] |
 | 4-(4-Imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-cyclohexanol | IC50 | 250.0 [1], 253.5 [2] |
 | 10-[(4-Bromophenyl)diazenyl]-1,3,4,8,12-pentazatricyclo[7.3.0.02,6]dodeca-2,5,7,11-tetraene-5,7,11-triamine | IC50 | 14000.0 [1], 58000.0 [2] |
 | 4-[2-(4-Fluoro-phenyl)-5-(4-methanesulfonyl-phenyl)-1H-pyrrol-3-yl]-pyridine | IC50 | 1080.0 [1], 6850.0 [2] |
 | Staurosporine | IC50 | 2270.0 [1] |
 | Sotrastaurin | IC50 | 10000.0 [1] |
 | Furaltadone | IC50 | 13500.0 [1] |
 | Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans- | IC50 | 5.0 [1] |
 | Neflamapimod | IC50 | 200000.0 [1] |
 | 2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide | IC50 | 42.0 [1] |
 | Amg-458 | IC50 | 100000.0 [1] |
 | 4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine | IC50 | 20.0 [1] |
 | 2-(2-(2-Methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | IC50 | 120.0 [1] |
 | 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[(5-nitro-2-thiazolyl)thio]-1H-1,2,4-triazol-5-one | IC50 | 500.0 [1] |
 | TCS JNK 5a | IC50 | 316.23 [1] |
 | 4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide | IC50 | 173.0 [1] |
 | Pyrimidone, 22 | IC50 | 100000.0 [1] |
 | 2-(2-Quinolin-3-Ylpyridin-4-Yl)-1,5,6,7-Tetrahydro-4h-Pyrrolo[3,2-C]pyridin-4-One | IC50 | 200000.0 [1] |
 | 2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-one | IC50 | 100000.0 [1] |
 | CID 72547959 | IC50 | 514.0 [1] |
 | N-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1,5-dimethyl-3-oxo-2-phenylpyrazole-4-carboxamide | IC50 | 100000.0 [1] |
 | N-[4-[3-(6-Methylpyridin-3-yl)-1,2,4-triazol-1-yl]phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine | IC50 | 283.0 [1] |
 | 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3-one | IC50 | 10000.0 [1] |
 | 4-[[9-[(3R)-3-Oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol | IC50 | 38.0 [1] |
 | 8-N-(2,2-Dimethylpropyl)-2-N-[2-ethoxy-4-(4-methyl-1,2,4-triazol-3-yl)phenyl]-6-methylpyrido[3,4-d]pyrimidine-2,8-diamine | IC50 | 76.0 [1] |
 | 2-[2-(2-Fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | IC50 | 21000.0 [1] |
 | 3-Nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide | IC50 | 7700.0 [1] |
 | CID 44814409 | IC50 | 10000.0 [1] |
 | 4-(4-Fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 195.0 [1] |
 | Methyl 3-(2-(4-methoxyphenyl)acetamido)thiophene-2-carboxylate | IC50 | 14100.0 [1] |
 | N-[3-Cyano-7-(cyclopropanecarbonyl)-5,6-dihydro-4H-thieno[2,3-b]pyridin-2-yl]naphthalene-1-carboxamide | IC50 | 316.23 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | IC50 | 1100.0 [1] |
 | Lck Inhibitor | IC50 | 40000.0 [1] |
 | N-(4-(Methylsulfonyl)benzyl)-4-amino-5-cyano-6-(cyclopropylmethoxy)picolinamide | IC50 | 47.0 [1] |
 | CID 25222038 | IC50 | 99.0 [1] |
 | Zuihonin A | IC50 | 2500.0 [1] |
 | 6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-1-carboxylic acid | IC50 | 200000.0 [1] |
 | N-(4-(Methylsulfonyl)benzyl)-4-amino-5-cyano-6-(thiophen-3-yl)picolinamide | IC50 | 390.0 [1] |
 | N-(4-(Methylsulfonyl)benzyl)-4-amino-5-cyano-6-(cyclopentylamino)picolinamide | IC50 | 290.0 [1] |
 | 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
 | Jnk-IN-7 | IC50 | 0.7 [1] |
 | 2-[[1-Cyclopentyl-5-[1-(Oxetan-3-Yl)piperidin-4-Yl]pyrazol-3-Yl]amino]pyridine-4-Carbonitrile | IC50 | 5000.0 [1] |
 | 1-Benzyl-4-(benzyloxy)pyridin-2(1H)-one | IC50 | 200000.0 [1] |
 | [5-(3-Amino-3-methyl-but-1-ynyl)-2-methoxy-phenyl]-[4-(2,4-difluoro-phenylamino)-phenyl]-methanone | IC50 | 10000.0 [1] |
 | 4-[4-(4-Fluorophenyl)-2-(1-methylpiperidin-4-yl)-1,3-thiazol-5-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amine | IC50 | 261.0 [1] |
 | 2-Phenyl-4-[3-(trifluoromethyl)phenyl]-5-(4-pyridyl)-1H-imidazole | IC50 | 910.0 [1] |
 | 4-(2,4-Diphenyl-1H-imidazol-5-yl)-N-methylpyrimidin-2-amine | IC50 | 175.0 [1] |
 | 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
 | 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
 | N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | IC50 | 150.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-phenylacetamide | IC50 | 770.0 [1] |
 | N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | IC50 | 70.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)isobutyramide | IC50 | 8400.0 [1] |
 | N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | IC50 | 64.0 [1] |
 | N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | IC50 | 7700.0 [1] |
 | 3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 10000.0 [1] |
Calculator
